Who owns ARTV?
Institutional ownership of Artiva Biotherapeutics Inc. from Form 13F, Q2 2026
71 institutional managers reported holding Artiva Biotherapeutics Inc. (ARTV) in Form 13F filings for Q2 2026, with 22,718,800 shares worth $220M. The largest reported holder was Viking Global Investors LP. Managers that filed both quarters added a net 5,884,334 shares (+35.0%). 39 opened new positions and 8 sold out.
- Funds holding
- 71
- Value held
- $220M
- New / sold out
- 39 / 8
- Net shares, same filers
- +35.0%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of ARTV
Share of 13F holdings is each fund's shares as a share of the 22,718,800 ARTV shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Viking Global Investors LP New+$25.3M
- Blackstone Inc. New+$23.3M
- Caligan Partners LP New+$16.8M
- Franklin Resources Inc Added+$14.3M
- Samsara Biocapital, LLC New+$9.3M
- Blue Owl Capital Holdings LP New+$8.5M
- Vanguard Capital Management LLC Added+$7.5M
- Nantahala Capital Management, LLC New+$5.8M
- Citadel Advisors LLC Added+$5.8M
- Propel Bio Management, LLC Added+$5.3M
Biggest sellers in Q2 2026
- Ra Capital Management, L.p. Sold out-$63.5M
- venBio Partners LLC Sold out-$3.4M
- Millennium Management LLC Sold out-$794K
- Two Sigma Investments, LP Trimmed-$354K
- Jane Street Group, LLC Sold out-$254K
- Panagora Asset Management Inc Sold out-$198K
- Sanctuary Advisors, LLC Sold out-$139K
- Morgan Stanley Trimmed-$137K
- OMERS ADMINISTRATION Corp Sold out-$73K
- Osaic Holdings, Inc. Sold out-$116
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $160M and sold $68.8M; 24 added and 2 trimmed.
Schedule 13D and 13G filings on ARTV
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-05-18VIKING GLOBAL INVESTORS LP SCHEDULE 13G filed by Artiva Biotherapeutics Inc.Schedule 13G
- 2025-04-24BlackRock, Inc. SCHEDULE 13G filed by Artiva Biotherapeutics Inc.Schedule 13G
Questions about ARTV ownership
- Who owns ARTV stock?
- 71 institutional investment managers reported ARTV positions in their Form 13F filings for Q2 2026, holding 22,718,800 shares worth $220M in total. Viking Global Investors LP reported the largest position.
- Are funds buying or selling ARTV?
- In Q2 2026, 39 managers opened new ARTV positions, 24 added, 2 trimmed and 8 sold out. Managers that filed in both quarters added a net 5,884,334 shares.
- How current is this ARTV institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to ARTV by CUSIP. Options are left out. ARTV news and filings · ARTV insider trades · Top funds